Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
2021 · Biomedicine & Pharmacotherapy · 23 citations
https://doi.org/10.1016/j.biopha.2021.111300
S
Subodh Kumar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
2.5K
Citations
24
h-index
40
i10-index
Subodh Kumar is an academic researcher from Texas Tech University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Computational Drug Discovery Methods. The author has an h-index of 24, co-authored 103 publications.
ORCID: 0000-0003-0553-387XPapers by this author
worksCytosolic phospholipase A2 (cPLA2) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages
2016 · Lipids in Health and Disease · 7 citations
https://doi.org/10.1186/s12944-016-0300-x
Investigating the novel-binding site of RPA2 on Menin and predicting the effect of point mutation of Menin through protein–protein interactions
2023 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-023-35599-2
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12097659
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat